Evidence map›Paper›PMID 32983889›Full record

ArticleIDCases2020

First case of IMP-15-producing

Daniel Goldenberger, Danielle Vuichard-Gysin, Kathrin Herzog, Vladimira Hinić, Helena Seth-Smith, Adrian Egli

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in IDCases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.1field-weighted citation impact, top 68% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
  3. In host evolution of beta lactam resistance during active treatment forFrontiers in cellular and infection microbiology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Daniel GoldenbergerDivision of Clinical Bacteriology and Mycology, University Hospital Basel and University of Basel, Basel, Switzerland.
Danielle Vuichard-GysinDivision of Infectious Diseases and Hospital Epidemiology, Thurgau Hospital Group, Muensterlingen and Frauenfeld, Switzerland.
Kathrin HerzogLaboratory for Clinical Microbiology, Thurgau Hospital Group, Muensterlingen and Frauenfeld, Switzerland.
Vladimira HinićDivision of Clinical Bacteriology and Mycology, University Hospital Basel and University of Basel, Basel, Switzerland.
Helena Seth-SmithDivision of Clinical Bacteriology and Mycology, University Hospital Basel and University of Basel, Basel, Switzerland.
Adrian EgliDivision of Clinical Bacteriology and Mycology, University Hospital Basel and University of Basel, Basel, Switzerland.
University Hospital of Basel · CHUniversity of Basel · CHSpital Thurgau (Switzerland) · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report on the first case of multiresistant

Indexed as

blaIMP-15Cabapenemase-producing Pseudomonas aeruginosaCambodiaMetallo-β-lactamaseSwitzerlandWhole genome sequencing (WGS)

Identifiers

PMID32983889
PMCPMC7494785
OpenAlexW3082623098

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.